Dr Reddy's Grows Consumer Health Offering In UK And US

Through a UK product launch and US acquisition, generics player Dr Reddy's is stepping up its interest in the consumer health market.

• Source: Shutterstock

Dr Reddy's Laboratories has expanded its consumer health offering with a UK product launch and US portfolio acquisition.

The Hyderabad, India-headquartered company has entered the UK OTC market with the launch of hay fever treatment Histallay. Containing 120...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

OptiBiotix Enters US Supplements Market With Hydroxycut

 
• By 

UK's OptiBiotix believes its SlimBiome probiotic can cut through in the crowded US market for weight loss supplements.

Stada Acquires Fortacell To Grow In Balkans

 
• By 

Stada's Serbian subsidiary Hemofarm has enhanced its offering in the dietary supplements category with the acquisition of Fortacell from Goodwill Pharma.

Vision Healthcare Strikes Deals To Expand European Offering

 
• By 

Belgium-based Vision Healthcare has acquired Svenskt Kosttillskott in Sweden and New Care Supplements in the Netherlands.

Portfolios In Large US Food Industry Merger Cleared By FTC Include Nutritional Supplements

 

FTC decision, says Bureau of Competition director Daniel Guarnera, influenced by both companies marketing different lines in different countries, limiting the number of similar products in the same categories the combined firm would offer.

More from Business